High IL-21 receptor expression and apoptosis induction by IL-21 in follicular lymphoma

被引:48
作者
Akamatsu, Norihiko
Yamada, Yasuaki
Hasegawa, Hiroo
Makabe, Koki
Asano, Ryutaro
Kumagai, Izumi
Murata, Ken
Maizum, Yoshitaka
Tsukasaki, Kunihiro
Tsuruda, Kazuto
Sugahara, Kazuyuki
AtogaMi, Sunao
Yanagihara, Katsunori
Kamihira, Shimeru
机构
[1] Nagasaki Univ, Grad Sch Biomed Sci, Dept Lab Med, Nagasaki 8528501, Japan
[2] Tohoku Univ, Grad Sch Engn, Dept Biomol Engn, Aoba Ku, Sendai, Miyagi 9809579, Japan
[3] Nagasaki Univ, Grad Sch Biomed Sci, Atom Bomb Dis, Dept hematol & Mol Med, Nagasaki 8528501, Japan
[4] Tottori Univ, Fac Med, Div Clin Lab Med & Hematol, Tottori 6838504, Japan
关键词
IL-21; apoptosis; follicular lymphoma; Bcl-2;
D O I
10.1016/j.canlet.2007.06.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We surveyed IL-21 receptor (IL-21R) in leukemia and lymphoma and found that follicular lymphoma cells showed exceptionally high IL-21R expression. Notably, IL-21 showed divergent effects depending on the cell origin: growth stimulation in Burkitt lymphoma cell lines and adult T cell leukemia/lymphoma cell lines but induction of apoptosis in B lymphoma cell lines with t(l4-,l8)(q32;q2l), a marker karyotype of follicular lymphoma. IL-21 activated caspase-8 and -3 and reduced mitochondrial membrane potential. More importantly, IL-21 decreased Bcl-2 expression but increased Bax expression. These results support a new therapeutic approach using the IL-21/IL-21R system in follicular lymphoma. (C) 2007 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:196 / 206
页数:11
相关论文
共 32 条
[1]   CD40 mediated human cholangiocyte apoptosis requires JAK2 dependent activation of STAT3 in addition to activation of JNK1/2 and ERK1/2 [J].
Ahmed-Choudhury, J ;
Williams, KT ;
Young, LS ;
Adams, DH ;
Afford, SC .
CELLULAR SIGNALLING, 2006, 18 (04) :456-468
[2]   Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling [J].
Alizadeh, AA ;
Eisen, MB ;
Davis, RE ;
Ma, C ;
Lossos, IS ;
Rosenwald, A ;
Boldrick, JG ;
Sabet, H ;
Tran, T ;
Yu, X ;
Powell, JI ;
Yang, LM ;
Marti, GE ;
Moore, T ;
Hudson, J ;
Lu, LS ;
Lewis, DB ;
Tibshirani, R ;
Sherlock, G ;
Chan, WC ;
Greiner, TC ;
Weisenburger, DD ;
Armitage, JO ;
Warnke, R ;
Levy, R ;
Wilson, W ;
Grever, MR ;
Byrd, JC ;
Botstein, D ;
Brown, PO ;
Staudt, LM .
NATURE, 2000, 403 (6769) :503-511
[3]   Antitumor activity of interleukin-21 prepared by novel refolding procedure from inclusion bodies expressed in Escherichia coli [J].
Asano, R ;
Kudo, T ;
Makabe, K ;
Tsumoto, K ;
Kumagai, I .
FEBS LETTERS, 2002, 528 (1-3) :70-76
[4]   Cutting edge:: The common γ-chain is an indispensable subunit of the IL-21 receptor complex [J].
Asao, H ;
Okuyama, C ;
Kumaki, S ;
Ishii, N ;
Tsuchiya, S ;
Foster, D ;
Sugamura, K .
JOURNAL OF IMMUNOLOGY, 2001, 167 (01) :1-5
[5]   Interleukin-21 is a growth and survival factor for human myeloma cells [J].
Brenne, AT ;
Ro, TB ;
Waage, A ;
Sundan, A ;
Borset, M ;
Hjorth-Hansen, H .
BLOOD, 2002, 99 (10) :3756-3762
[6]   The role of STATs in transcriptional control and their impact on cellular function [J].
Bromberg, J ;
Darnell, JE .
ONCOGENE, 2000, 19 (21) :2468-2473
[7]   Stat3 as an oncogene [J].
Bromberg, JF ;
Wrzeszczynska, MH ;
Devgan, G ;
Zhao, YX ;
Pestell, RG ;
Albanese, C ;
Darnell, JE .
CELL, 1999, 98 (03) :295-303
[8]   Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis [J].
Chin, YE ;
Kitagawa, M ;
Kuida, K ;
Flavell, RA ;
Fu, XY .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (09) :5328-5337
[9]   Interleukin-21 receptor (IL-21R) is up-regulated by CD40 triggering and mediates proapoptotic signals in chronic lymphocytic leukemia B cells [J].
de Totero, D ;
Meazza, R ;
Zupo, S ;
Cutrona, G ;
Matis, S ;
Colombo, M ;
Balleari, E ;
Pierri, I ;
Fabbi, M ;
Capaia, M ;
Azzarone, B ;
Gobbi, M ;
Ferrarini, M ;
Ferrini, S .
BLOOD, 2006, 107 (09) :3708-3715
[10]   IL-21 induces tumor rejection by specific CTL and IFN-γ-dependent CXC chemokines in syngeneic mice [J].
Di Carlo, E ;
Comes, A ;
Orengo, AM ;
Rosso, O ;
Meazza, R ;
Musiani, P ;
Colombo, MP ;
Ferrini, S .
JOURNAL OF IMMUNOLOGY, 2004, 172 (03) :1540-1547